This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Mucinous and mucinous cystic tumor
C3_OVARY_MUCINO
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
194 |
4. Check minimum number of eventsNone |
194 |
5. Include endpointsNone |
194 |
6. Filter based on genotype QC (FinnGen only) |
176 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor
based on the number of shared cases.
Similar with more cases:
- Mucinous and mucinous cystic tumor, including Hilmo
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 176 | 176 | - |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | - |
| Median age at first event (years) | 52.08 | 52.08 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 178
- Matched controls
- 1780
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
194.1
149
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
68.6
134.3
78
20
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
119.7
101
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
88.0
77
*
JEA00
NOMESCO Finland
Appendectomy
24.5
87.0
72
48
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
27.7
75.1
56
29
LCD00
NOMESCO Finland
Hysterectomy
20.3
73.1
65
49
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
33.4
71.7
49
20
JAL30
NOMESCO Finland
Omentectomy
159.1
68.8
69
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
37.5
66.0
43
15
128
Kela drug reimbursment
Cancers of female genital organs
+∞
61.0
55
*
A04AA01
ATC
ondansetron; systemic, rectal
25.5
53.7
40
20
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
45.8
42
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
39.0
36
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
15.3
37.8
36
29
H02AB02
ATC
dexamethasone; systemic
44.9
32.2
39
11
B01AB10
ATC
tinzaparin; parenteral
7.3
29.3
52
95
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.7
26.9
44
73
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
25.6
24
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
23.9
68
190
JAL00
NOMESCO Finland
Biopsy of peritoneum
75.5
23.5
26
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
23.4
22
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
5.6
23.4
57
139
JN4BD
NOMESCO Finland
Extensive body CT
10.8
23.2
27
29
JN4AD
NOMESCO Finland
Body CT examination
8.7
22.4
31
42
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.2
21.9
59
156
121
Kela drug reimbursment
Severe hypofunction of sexual glands
25.5
21.7
30
14
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
28.5
21.7
29
12
L03AA13
ATC
pegfilgrastim; parenteral
+∞
21.3
20
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
21.3
20
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
21.3
20
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
30.2
19.8
26
10
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.9
17.9
104
473
A04AA02
ATC
granisetron; systemic, transdermal
186.8
16.8
17
*
Z31.5
ICD-10 Finland
Genetic counselling
7.5
16.2
25
38
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.9
15
*
B01AB05
ATC
enoxaparin; parenteral
3.6
15.8
85
360
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
7.4
14.9
23
35
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.8
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.7
13
*
130
Kela drug reimbursment
Malignant tumour
+∞
13.7
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
12.6
12
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
12.2
31
76
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
11.6
11
*
L03AA02
ATC
filgrastim; parenteral
+∞
11.6
11
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
11.6
11
*
WX402
NOMESCO Finland
General anaesthesia
3.3
11.6
56
216
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.7
11.1
20
19
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
17.4
10.6
16
10
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
116.6
10.5
11
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
10.5
10
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
42.7
10.1
12
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
105.4
9.5
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.5
9
*
C567, ,
ICD-10 Finland
+∞
9.5
9
*
Z51.5
ICD-10 Finland
Palliative care
8.0
8.7
19
26
R18
ICD-10 Finland
Ascites
17.4
8.7
13
8
TPX10
NOMESCO Finland
Implantation of vascular injection port
29.1
8.6
11
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
94.3
8.5
9
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
8.4
8
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.6
7.7
13
11
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
JAH01
NOMESCO Finland
Laparoscopy
4.7
7.1
17
39
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
17.5
6.8
10
6
HA1AA
NOMESCO Finland
X-ray mammography
4.3
6.8
18
45
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
23.6
6.7
9
*
L02BG04
ATC
letrozole; oral
9.8
6.4
12
13
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
A04AA03
ATC
tropisetron; systemic
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
13.1
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
84
13.40
59.89
2.2
1.5
13.96
2.59
ug/l
1.38
59
62
12
7
18.24
8.19
1.2
1.6
—
—
—
0
0
6
0
+∞
6.28
1.2
0.0
38.93
—
u/ml
—
6
0
31
139
2.49
4.57
11.3
5.3
0.76
1.37
mmol/l
0.43
25
120
98
687
1.95
4.56
2.6
2.3
—
—
estimate
—
0
0
6
5
12.35
3.79
3.0
2.4
0.50
1.20
index
—
6
5
91
667
1.75
3.31
4.6
3.2
35.38
36.47
g/l
0.92
86
622
53
339
1.80
3.03
1.9
1.9
—
—
—
0
0
7
14
5.16
2.75
1.1
1.0
—
—
—
0
0
90
690
1.62
2.55
7.1
4.5
1.21
1.22
mmol/l
0.98
80
626
9
27
3.45
2.43
1.1
1.0
—
—
—
0
0
143
1569
0.55
2.40
4.6
5.2
5.78
5.86
mmol/l
0.45
128
1450
8
22
3.76
2.39
1.1
1.1
—
—
—
0
0
8
22
3.76
2.39
1.1
1.0
—
—
—
0
0
142
1557
0.56
2.26
6.8
6.2
1.77
1.86
mu/l
0.36
131
1455
96
771
1.53
2.08
7.6
5.0
1.20
1.22
mmol/l
1.24
79
665
9
34
2.73
1.89
2.9
2.3
—
—
—
0
0
19
328
0.53
1.88
1.4
1.7
—
—
—
0
0
16
80
2.10
1.86
15.2
6.1
24.96
25.38
mmol/l
0.16
16
80
6
17
3.61
1.85
1.8
1.1
—
—
—
0
0
5
13
3.92
1.72
1.4
1.7
64.80
64.69
umol/l
—
5
13
149
1597
0.59
1.71
5.0
6.0
2.91
2.79
mmol/l
0.99
139
1491
6
19
3.23
1.67
1.7
1.1
—
—
—
0
0
147
1575
0.62
1.54
4.4
5.2
4.96
4.81
mmol/l
1.17
137
1472
5
15
3.40
1.53
1.2
1.1
—
—
—
0
0
26
165
1.67
1.51
1.5
1.7
—
—
—
0
0
25
157
1.69
1.50
1.4
1.7
—
—
—
0
0
103
876
1.42
1.47
7.4
3.9
6.51
6.51
mmol/l
0.00
96
809
143
1534
0.66
1.35
17.1
12.1
83.41
80.42
ml/min/173m2
1.05
126
1401
6
25
2.45
1.25
1.2
1.3
—
—
—
0
0
6
25
2.45
1.25
1.2
1.3
—
—
—
0
0
6
25
2.45
1.25
1.0
1.2
—
—
—
0
0
98
845
1.36
1.19
13.4
5.9
3.99
4.12
e9/l
0.21
75
720
141
1508
0.69
1.16
5.4
6.5
39.13
38.93
mmol/mol
0.11
132
1425
148
1567
0.67
1.11
4.4
5.1
1.61
1.60
mmol/l
0.07
136
1459
7
32
2.23
1.09
1.7
1.1
—
—
—
0
0
158
1649
0.63
1.05
13.4
9.8
23.27
22.88
u/l
0.13
150
1599
24
166
1.52
1.01
13.1
4.8
104.88
104.43
mmol/l
0.16
24
166
11
62
1.83
0.96
2.3
2.3
14017.40
3706.95
u/l
—
5
26
112
1229
0.76
0.95
4.8
4.5
14.38
11.45
mm/h
1.12
105
1136
5
104
0.47
0.92
1.0
1.1
—
—
—
0
0
31
231
1.41
0.91
4.5
3.0
4.73
4.58
e6/l
0.02
15
93
141
1495
0.73
0.90
3.8
4.3
1.26
1.23
mmol/l
0.22
124
1371
13
80
1.67
0.87
18.8
6.4
0.69
0.66
%
0.16
13
80
13
80
1.67
0.87
18.2
6.4
1.39
1.28
%
0.25
13
80
30
225
1.40
0.85
1.6
1.7
—
—
—
0
0
89
786
1.26
0.80
7.2
3.3
9.42
10.31
umol/l
0.67
83
738
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
6
34
1.79
0.77
1.8
1.0
—
—
—
0
0
89
988
0.80
0.74
2.5
3.3
—
—
—
0
0
127
1177
1.28
0.73
7.7
5.3
78.34
76.33
u/l
0.26
116
1091
7
40
1.78
0.72
1.7
1.5
—
0.05
—
0
6
13
191
0.66
0.71
2.0
2.1
—
—
—
0
0
41
496
0.77
0.71
1.7
1.7
19.42
21.46
nmol/l
0.47
36
418
149
1556
0.74
0.70
16.1
12.4
27.72
18.30
mg/l
2.68
130
1218
7
116
0.59
0.70
1.3
1.4
—
42.78
—
0
10
32
252
1.33
0.69
4.2
2.8
1.02
1.36
e6/l
0.36
16
115
5
92
0.53
0.69
1.2
1.6
—
—
—
0
0
12
176
0.66
0.66
1.8
1.9
—
—
—
0
0
49
417
1.24
0.59
4.6
3.0
0.16
0.52
e6/l
2.37
35
295
58
503
1.23
0.59
3.0
2.1
53.28
58.31
u/l
0.29
50
464
6
36
1.69
0.57
1.7
1.3
0.28
1.51
ug/l
—
6
30
69
772
0.83
0.57
2.1
2.1
97.66
100.18
pmol/l
0.16
30
364
48
555
0.81
0.55
3.5
3.8
2.48
6.56
mg/mmol
0.95
28
312
70
780
0.83
0.55
2.2
2.6
77.74
80.11
nmol/l
0.27
61
701
34
403
0.81
0.49
4.3
3.9
1.01
1.02
kg/l
0.72
20
265
7
46
1.54
0.49
1.3
1.2
—
—
—
0
0
5
82
0.60
0.47
1.6
1.5
984.30
908.96
mu/l
—
5
67
12
160
0.73
0.42
2.4
1.5
1.33
1.32
%
0.06
12
145
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
17
212
0.78
0.38
4.1
4.9
39.33
33.32
%
—
9
130
15
117
1.31
0.36
7.1
3.9
4.43
4.56
pmol/l
0.24
15
104
15
187
0.78
0.34
4.5
5.8
—
—
—
0
0
7
98
0.70
0.31
2.4
1.4
—
—
—
0
0
7
52
1.36
0.31
1.3
1.9
0.30
0.23
g/l
—
7
52
35
394
0.86
0.30
1.3
1.4
111.07
32.89
iu/ml
0.55
11
130
17
140
1.24
0.28
4.0
3.2
—
—
—
0
0
11
138
0.78
0.26
1.5
1.4
—
—
—
0
0
11
87
1.28
0.25
1.3
1.6
—
—
—
0
0
133
1369
0.89
0.24
5.6
5.1
15.04
14.76
pmol/l
0.64
122
1261
56
521
1.11
0.22
4.4
3.0
—
—
—
0
0
51
473
1.11
0.21
4.1
3.5
0.00
0.00
estimate
-0.00
14
139
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
4.75
—
0
10
0
10
0.00
0.21
0.0
1.2
—
64.02
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1.08
—
0
6
10
80
1.26
0.21
4.8
2.7
26.57
24.59
mmol/l
—
10
80
10
80
1.26
0.21
1.5
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
12
99
1.23
0.20
1.3
1.7
—
—
—
0
0
40
368
1.11
0.19
1.2
1.3
3.59
11.86
u/ml
1.42
16
138
10
81
1.25
0.19
1.3
2.4
0.97
1.14
%
—
10
81
92
883
1.09
0.19
4.5
4.1
0.00
0.02
estimate
0.50
23
176
5
69
0.72
0.17
1.6
1.6
—
—
—
0
0
25
276
0.89
0.16
1.8
1.7
1269.50
1116.55
nmol/l
0.21
12
206
44
468
0.92
0.15
3.2
3.0
622.91
1022.92
ng/l
1.12
38
383
103
1060
0.93
0.14
3.5
3.0
44.37
37.42
u/l
0.40
89
996
16
141
1.15
0.14
3.9
2.7
3.76
2.37
mmol/l
0.70
16
124
50
474
1.08
0.13
4.0
4.0
0.00
0.00
estimate
-0.00
21
167
20
182
1.11
0.11
7.0
3.0
0.96
1.02
mmol/l
0.52
20
153
34
320
1.08
0.10
1.4
1.8
470.11
453.09
pmol/l
0.08
28
263
5
46
1.09
0.09
1.0
1.2
—
10.89
—
0
8
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
42
436
0.95
0.06
1.3
1.3
1.47
1.60
u/ml
0.05
15
126
59
607
0.96
0.06
3.4
3.7
18.46
187.81
ng/l
0.83
38
400
12
109
1.11
0.06
1.2
1.7
—
—
—
0
0
89
874
1.04
0.06
4.6
4.0
0.00
0.00
estimate
-0.00
23
184
41
396
1.05
0.05
1.3
1.5
—
—
—
0
0
40
387
1.04
0.05
3.4
2.0
320.26
314.38
umol/l
0.12
35
339
88
867
1.03
0.04
4.6
3.9
0.00
0.00
estimate
-0.00
22
177
58
568
1.03
0.04
4.4
1.9
2.39
2.36
mmol/l
0.60
52
507
15
158
0.94
0.02
1.3
1.3
268.60
119.27
u/ml
—
5
66
14
133
1.06
0.01
1.7
2.9
64.86
69.67
ng/l
0.22
14
113
66
658
1.00
0.00
4.4
3.8
0.00
0.04
estimate
0.96
14
138
12
117
1.03
0.00
7.8
1.4
65.85
67.48
g/l
0.60
12
108
0
7
0.00
-0.00
0.0
1.0
—
9.90
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
9.80
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.01
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.2
—
534.44
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
37.88
—
0
5
5
53
0.94
-0.00
1.4
2.8
38.00
42.32
u/l
—
5
47
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
99.83
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO – Mucinous and mucinous cystic tumor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).